STRENSIQ (ASFOTASE ALFA) — FDA Approval BLA125513 (ALEXION PHARM)
STRENSIQ (ASFOTASE ALFA) — FDA Approval BLA125513 (ALEXION PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: STRENSIQ; Active ingredients: ASFOTASE ALFA; Application number: BLA125513.
| Brand name | STRENSIQ |
|---|---|
| Active ingredients | ASFOTASE ALFA |
| Application number | BLA125513 |
| Sponsor | ALEXION PHARM |
| Dosage form | SOLUTION |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 4 |
| First approval date | 20151023 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →